Skip to main content
. 2023 Apr 12;2023(4):CD015322. doi: 10.1002/14651858.CD015322.pub2

1.3. Analysis.

1.3

Comparison 1: Triptans versus placebo, Outcome 3: Improvement in other migrainous symptoms